Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 1072261Generated: October 26, 2026

(RS)-N,N-dimethyl-{2-[4-(alpha-phenyl-p-chloro-benzyl)piperazin-1-yl]ethoxy}-acetamide → Cetirizine Hydrochloride

https://huagongshe.com/reaction/1072261

Reaction equation

Participants

RoleNameHCIDCharge
Reactant(RS)-N,N-dimethyl-{2-[4-(alpha-phenyl-p-chloro-benzyl)piperazin-1-yl]ethoxy}-acetamideHCID 10180126—
Reactant(RS)-N,N-dimethyl-{2-[4-(alpha-phenyl-p-chloro-benzyl)piperazin-1-yl]ethoxy}-acetamide dihydrochlorideHCID 22391908—
ProductCetirizine HydrochlorideHCID 5518281.3%

Reaction Steps

The procedure described in Example 13 is followed with the difference that, instead of the (RS)-N,N-dimethyl-{2-[4-(α-phenyl-p-chloro-benzyl)piperazin-1-yl]ethoxy}-acetamide dihydrochloride, 83.2 g (0.2 moles) of (RS)-N,N-dimethyl-{2-[4-(α-phenyl-p-chloro-benzyl)piperazin-1-yl]ethoxy}-acetamide base are used. Thus, 75.0 g (81.3%) of the title compound are obtained, m.p. 225-228° C. The purity of the product corresponds to the quality requirements given in Eur. Pharm., 3, 1997, 1084.

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS06908999B2
Source datasetuspto-grants-2005_06
ORD IDord-8dd11db6e67648d7856bdcb55c7afbb6
Source noteuspto-grants-2005_06